Financials
- Market Capitalization 12.55 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
146.72
市销率
3.28
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 699 | BBIO BridgeBio Pharma, Inc. - Common Stock | 76.87 USD | +0.37% | -4.53% | -5.37% | +34.86% | 15.03 B USD | ||
| 740 | EXEL Exelixis, Inc. - Common Stock | 55.53 USD | +1.63% | -0.72% | +5.51% | +42.24% | 13.76 B USD | ||
| 794 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 537.85 USD | -0.40% | +4.65% | +16.38% | +26.97% | 12.43 B USD | ||
| 796 | CORT Corcept Therapeutics Incorporated - Common Stock | 114.58 USD | +1.09% | -6.19% | +0.37% | +56.17% | 12.39 B USD |